EN The xCELLigence system adds on our capabilities enabling real-time monitoring of cytotoxicity of cell therapies and antibodies/bispecifics against tumor cell lines or healthy primary cells. Performing co-cultures with these cell types will allow us to better assess in vitro efficacy and safety of various therapies on a wider range of diseased and healthy tissues.
Charles River
The Netherlands